Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo

Breast Cancer Research and Treatment

Volumn 143, Issue 2, 2014, Pages 287-299

  Hu, Yunhui ^a,b,c   Li, Shuangjing ^a,d   Yang, Ming ^a   Yan, Cihui ^a   Fan, Dongmei ^a   Zhou, Yuan ^a   Zhang, Yanjun ^a   Yagüe, Ernesto ^b   Xiong, Dongsheng ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

Breast cancer stem cells; E cadherin; EMT; Sorcin

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD24 ANTIGEN; DOXORUBICIN; HERMES ANTIGEN; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA; SORCIN; UVOMORULIN; VASCULOTROPIN; ALDEHYDE DEHYDROGENASE ISOENZYME 1; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; CALCIUM BINDING PROTEIN; CD24 PROTEIN, HUMAN; CD44 PROTEIN, HUMAN; ETOPOSIDE; ISOENZYME; RETINAL DEHYDROGENASE; SMALL INTERFERING RNA; SRI PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER STEM CELL; CELL MIGRATION; CONTROLLED STUDY; DRUG SENSITIZATION; EMBRYO; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; TUMOR INVASION; ADENOCARCINOMA; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG RESISTANCE; FEMALE; FIBROSARCOMA; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MCF 7 CELL LINE; MULTICELLULAR SPHEROID; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; SECONDARY; TUMOR CELL CULTURE;

ADENOCARCINOMA; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD24; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; ETOPOSIDE; FEMALE; FIBROSARCOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MCF-7 CELLS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; RETINAL DEHYDROGENASE; RNA INTERFERENCE; RNA, SMALL INTERFERING; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84893670409     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2809-2     Document Type: Article

References (52)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100(7):3983-3988. doi: 10.1073/pnas.05302911000530291100
2. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704-715. doi: 10.1016/j.cell.2008.03.027
3. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1(3):313-323. doi: 10.1016/j.stem.2007.06.002
4. Giannoni E, Bianchini F, Masieri L, Serni S, Torre E, Calorini L, Chiarugi P (2010) Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 70(17):6945-6956. doi: 10.1158/0008-5472.CAN-10-0785
5. Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5(4):275-284. doi: 10.1038/nrc1590
6. Zhang W, Feng M, Zheng G, Chen Y, Wang X, Pen B, Yin J, Yu Y, He Z (2012) Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells. Biochem Biophys Res Commun 417(2):679-685. doi: 10.1016/j.bbrc.2011.11.142
7. Saxena M, Stephens MA, Pathak H, Rangarajan A (2011) Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis 2:e179. doi: 10.1038/cddis.2011.61
8. Haslehurst AM, Koti M, Dharsee M, Nuin P, Evans K, Geraci J, Childs T, Chen J, Li J, Weberpals J, Davey S, Squire J, Park PC, Feilotter H (2012) EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer 12:91. doi: 10.1186/1471-2407-12-91
9. Zhu K, Chen L, Han X, Wang J, Wang J (2012) Short hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells. Oncol Rep 27(4):1027-1034
10. Meyers MB, Pickel VM, Sheu SS, Sharma VK, Scotto KW, Fishman GI (1995) Association of sorcin with the cardiac ryanodine receptor. J Biol Chem 270(44):26411-26418
11. Deng L, Su T, Leng A, Zhang X, Xu M, Yan L, Gu H, Zhang G (2010) Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer. Med Oncol 27(4):1102-1108. doi: 10.1007/s12032-009-9342-5
12. Yokota T, Kouno J, Adachi K, Takahashi H, Teramoto A, Matsumoto K, Sugisaki Y, Onda M, Tsunoda T (2006) Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin. Acta Neuropathol 111(1):29-38. doi: 10.1007/s00401-005-1085-6
13. Diaz-Blanco E, Bruns I, Neumann F, Fischer JC, Graef T, Rosskopf M, Brors B, Pechtel S, Bork S, Koch A, Baer A, Rohr UP, Kobbe G, von Haeseler A, Gattermann N, Haas R, Kronenwett R (2007) Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia 21(3):494-504 10.1038/sj.leu.2404549
14. Tan Y, Li G, Zhao C, Wang J, Zhao H, Xue Y, Han M, Yang C (2003) Expression of sorcin predicts poor outcome in acute myeloid leukemia. Leuk Res 27(2):125-131
15. Landriscina M, Laudiero G, Maddalena F, Amoroso MR, Piscazzi A, Cozzolino F, Monti M, Garbi C, Fersini A, Pucci P, Esposito F (2010) Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents. Cancer Res 70(16):6577-6586. doi: 10.1158/0008-5472.CAN-10-1256
16. Parekh HK, Deng HB, Choudhary K, Houser SR, Simpkins H (2002) Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells. Biochem Pharmacol 63(6):1149-1158
17. Qu Y, Yang Y, Liu B, Xiao W (2010) Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer. Med Oncol 27(4):1303-1308. doi: 10.1007/s12032-009-9379-5
18. Zhou Y, Xu Y, Tan Y, Qi J, Xiao Y, Yang C, Zhu Z, Xiong D (2006) Sorcin, an important gene associated with multidrug-resistance in human leukemia cells. Leuk Res 30(4):469-476. doi: 10.1016/j.leukres.2005.08.024
19. Yague E, Armesilla AL, Harrison G, Elliott J, Sardini A, Higgins CF, Raguz S (2003) P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation. J Biol Chem 278(12):10344-10352. doi: 10.1074/jbc.M211093200
20. Su Y, Cheng X, Tan Y, Hu Y, Zhou Y, Liu J, Xu Y, Xie Y, Wang C, Gao Y, Wang J, Cheng T, Yang C, Xiong D, Miao H (2012) Synthesis of a dual functional anti-MDR tumor agent PH II-7 with elucidations of anti-tumor effects and mechanisms. PLoS One 7(3):e32782
21. Lombardo Y, Filipovic A, Molyneux G, Periyasamy M, Giamas G, Hu Y, Trivedi PS, Wang J, Yague E, Michel L, Coombes RC (2012) Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo. Proc Natl Acad Sci USA 109(41):16558-16563. doi: 10.1073/pnas.1206268109
22. Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8(8):592-603
23. Charafe-Jauffret E, Ginestier C, Birnbaum D (2009) Breast cancer stem cells: tools and models to rely on. BMC Cancer 9:202. doi: 10.1186/1471-2407-9- 202
24. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871-890. doi: 10.1016/j.cell.2009.11.007
25. Singh A, Settleman J (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29(34):4741-4751. doi: 10.1038/onc.2010.215
26. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of atp-dependent transporters. Nat Rev Cancer 2:48-58
27. Kakarala M, Wicha MS (2007) Cancer stem cells: implications for cancer treatment and prevention. Cancer J 13(5):271-275. doi: 10.1097/PPO. 0b013e318156da4e
28. Bastid J (2012) EMT in carcinoma progression and dissemination: facts, unanswered questions, and clinical considerations. Cancer Metastasis Rev 31(1-2):277-283. doi: 10.1007/s10555-011-9344-6
29. Ksiazkiewicz M, Markiewicz A, Zaczek AJ (2012) Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells. Pathobiology 79(4):195-208. doi: 10.1159/000337106
30. Zheng BB, Zhang P, Jia WW, Yu LG, Guo XL (2012) Sorcin, a potential therapeutic target for reversing multidrug resistance in cancer. J Physiol Biochem 68(2):281-287
31. Maddalena F, Laudiero G, Piscazzi A, Secondo A, Scorziello A, Lombardi V, Matassa DS, Fersini A, Neri V, Esposito F, Landriscina M (2011) Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasis. Cancer Res 71(24):7659-7669. doi: 10.1158/0008-5472.CAN-11-2172
32. Qi J, Liu N, Zhou Y, Tan Y, Cheng Y, Yang C, Zhu Z, Xiong D (2006) Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis. Biochem Biophys Res Commun 349(1):303-309. doi: 10.1016/j.bbrc.2006.08.042
33. Farrell EF, Antaramian A, Rueda A, Gomez AM, Valdivia HH (2003) Sorcin inhibits calcium release and modulates excitation-contraction coupling in the heart. J Biol Chem 278(36):34660-34666. doi: 10.1074/jbc.M305931200
34. Rizzuto R, Pozzan T (2006) Microdomains of intracellular Ca2+: molecular determinants and functional consequences. Physiol Rev 86(1):369-408. doi: 10.1152/physrev.00004.2005
35. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H (2007) NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26(5):711-724
36. Hoshino H, Miyoshi N, Nagai K, Tomimaru Y, Nagano H, Sekimoto M, Doki Y, Mori M, Ishii H (2009) Epithelial-mesenchymal transition with expression of SNAI1-induced chemoresistance in colorectal cancer. Biochem Biophys Res Commun 390(3):1061-1065. doi: 10.1016/j.bbrc.2009.10.117
37. Rosano L, Cianfrocca R, Spinella F, Di Castro V, Nicotra MR, Lucidi A, Ferrandina G, Natali PG, Bagnato A (2011) Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Clin Cancer Res 17(8):2350-2360. doi: 10.1158/1078-0432.CCR-10-2325-0432.CCR-10-2325
38. Davis FM, Kenny PA, Soo ET, van Denderen BJ, Thompson EW, Cabot PJ, Parat MO, Roberts-Thomson SJ, Monteith GR (2011) Remodeling of purinergic receptor-mediated Ca2+ signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cells. PLoS One 6(8):e23464
39. Hu J, Qin K, Zhang Y, Gong J, Li N, Lv D, Xiang R, Tan X (2011) Downregulation of transcription factor Oct4 induces an epithelial-to-mesenchymal transition via enhancement of Ca2+ influx in breast cancer cells. Biochem Biophys Res Commun 411(4):786-791
40. Chen J, Wang M, Xi B, Xue J, He D, Zhang J, Zhao Y (2012) SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer. PLoS One 7(8):e42413. doi: 10.1371/journal.pone.0042413
41. Rudland PS, Platt-Higgins A, Renshaw C, West CR, Winstanley JH, Robertson L, Barraclough R (2000) Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 60(6):1595-1603
42. Wang G, Platt-Higgins A, Carroll J, de Rudland Silva S, Winstanley J, Barraclough R, Rudland PS (2006) Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res 66(2):1199-1207
43. Chen M, Bresnick AR, O'Connor KL (2012) Coupling S100A4 to Rhotekin alters Rho signaling output in breast cancer cells. Oncogene. doi: 10.1038/onc.2012.383
44. Chen H, Yuan Y, Zhang C, Luo A, Ding F, Ma J, Yang S, Tian Y, Tong T, Zhan Q, Liu Z (2012) Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation. J Biol Chem 287(21):17109-17119
45. Lu D, Chen S, Tan X, Li N, Liu C, Li Z, Liu Z, Stupack DG, Reisfeld RA, Xiang R (2012) Fra-1 promotes breast cancer chemosensitivity by driving cancer stem cells from dormancy. Cancer Res 72(14):3451-3456
46. Sajithlal GB, Rothermund K, Zhang F, Dabbs DJ, Latimer JJ, Grant SG, Prochownik EV (2010) Permanently blocked stem cells derived from breast cancer cell lines. Stem Cells 28(6):1008-1018. doi: 10.1002/stem.424
47. Ling H, Sylvestre JR, Jolicoeur P (2010) Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors. Oncogene 29(32):4543-4554
48. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646-674. doi: 10.1016/j.cell.2011.02.013
49. Kowanetz M, Ferrara N (2006) Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res 12(17):5018-5022
50. Patton AM, Kassis J, Doong H, Kohn EC (2003) Calcium as a molecular target in angiogenesis. Curr Pharm Des 9(7):543-551
51. Lodola F, Laforenza U, Bonetti E, Lim D, Dragoni S, Bottino C, Ong HL, Guerra G, Ganini C, Massa M, Manzoni M, Ambudkar IS, Genazzani AA, Rosti V, Pedrazzoli P, Tanzi F, Moccia F, Porta C (2012) Store-operated Ca2+ entry is remodelled and controls in vitro angiogenesis in endothelial progenitor cells isolated from tumoral patients. PLoS One 7(9):e42541
52. Scheel C, Weinberg RA (2012) Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol 22(5-6):396-403